ABSTRACT BACKGROUND Risk prediction in elderly patients is increasingly relevant due to longer life expectancy.
suitable in older persons, as they are derived from populations of none or only few persons age $65 years (3, 4) . Moreover, conventional risk factors are not as influential in the development of CVD in this age group as they are in the middle-age population (5) , and consequently, other risk markers are needed.
Electrocardiographic (ECG) changes carry a large potential of such a marker. Their prevalence increases rapidly in this age group (6); they are easily assessed in most clinical settings; and they are a marker of direct pathology, representing at least some level of subclinical, cardiac impairment. In addition, the past 50 years, a number of studies have shown that ECG changes are strongly associated with future CVD in persons who are not previously diagnosed with the condition (7) (8) (9) (10) (11) (12) .
Although use of the ECG in risk prediction is not currently recommended in asymptomatic individuals (13) , it may be very well suited for this purpose in the subgroup of persons age $65 years. Therefore, we hypothesized that risk prediction of persons age $65 years would be improved by adding ECG changes. To test this, we examined whether adding ECG changes to the European Heart Score (3), the Framingham Global Risk Score (14) , and the con- Jørgensen et al. Jørgensen et al.
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ECG for Risk Prediction in the Elderly S E P T E M B E R 2 , 2 0 1 4 : 8 9 8 -9 0 6 whereas measurement of high-density lipoprotein cholesterol was not available at the first examination and only measured on a subgroup of the persons at the second examination. Diabetes mellitus was defined as plasma glucose concentration $11.1 mmol/l, use of insulin, other antidiabetic medicine, or selfreported disease (15, 16) . Resting heart rate was read from the ECG. Kaplan-Meier plots of proportion free of fatal cardiovascular disease (CVD) and proportion free of fatal or nonfatal CVD stratified by presence and severity of electrocardiographic (ECG) changes, respectively.
Jørgensen et al. Heart Score and the Framingham Global Risk Score, respectively, were calculated on all participants using previously published formulas (3, 14) . Missing values of high-density lipoprotein cholesterol for calculation of Framingham Global Risk Score was set to the mean value of the remaining participants.

Multivariable analyses shown in the Central
Illustration were performed using Cox proportional hazards regression models using all available followup and with adjustments for European Heart Score, Univariable analyses of the associations of each ECG change and the combined ECG changes with the endpoints of fatal CVD and the combination of fatal or nonfatal CVD. Levels of significance: *p < 0.05, **p < 0.01, and ***p < 0.001. CI ¼ confidence interval; HR ¼ hazard ratio; other abbreviations as in Figure 2 .
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bootstrapping. Cox model discrimination was assessed using the C-statistics and categorical and continuous net reclassification index (NRI). These statistics require a binary response, so the persons with <10 years of follow-up were excluded. Adding all ECG changes as present or not was marginally better judged by the clinically relevant NRI. For that reason and for the sake of simplicity, the equations presented for calculating absolute risks are based on these models. Also, they were used for creating risk categories for categorical NRI for both endpoints.
All statistical calculations were made using R Tables 1 and 2 . Step 1. Calculate I using regression coefficients. Regression coefficients for calculatingI 
Abbreviations as in
Step 2. Calculate estimated risks. ECG change and resting heart rate to the conventional risk factors are found in Table 2 and Online Table 1 . It is apparent, that though adding resting heart rate to the model with the conventional risk factors and ECG changes improved the C-index, the models without the resting heart rate had superior performance judged by the clinically relevant NRI. For this reason, the models with the conventional risk factors and the ECG changes were chosen as the final models. The results of the statistical tests for these models' discrimination based on 10,000 bootstrap samples are shown in Table 3 and Online Jørgensen et al.
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ECG for Risk Prediction in the Elderly digital encodings and could not examine the usefulness of digitally coded ECG changes in relation to improving risk prediction.
CONCLUSIONS
Based on these results, we have shown that CVD risk prediction in persons age $65 years is improved significantly by adding ECG changes to the conventional risk factors.
